AI assistant
INSMED Inc — Director's Dealing 2022
May 18, 2022
30150_dirs_2022-05-18_c1b57121-0b77-47b9-9d92-10eb785d4faa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-05-16
Reporting Person: Lewis William (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-16 | Common Stock | S | 3398 | $18.35 | Disposed | 261824 | Direct |
| 2022-05-17 | Common Stock | S | 5996 | $20.18 | Disposed | 255828 | Direct |
Footnotes
F1: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
F2: This is the weighted average sales price representing the shares sold at prices ranging from $18.30 to $18.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing the shares sold at prices ranging from $20.07 to $20.24 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.